Skip to main content

Compugen Reveals New Customers

NEW YORK, Dec 11 - Compugen revealed Monday a host of new companies that recently signed on as customers of its products and services.

A Compugen spokeswoman said that “over the past few months” AlphaGene, Avalon Pharmaceuticals, Aventis Pharmaceuticals, Chugai Biopharmaceuticals, Scios, and Serono had all become customers of either its LabOnWeb portal, its full-gene-structure reports, or its custom-tailored analysis services.

In addition, Motorola recently announced that it would use Compugen’s chip design services in the development and manufacture of some of its DNA biochips.

On Monday Compugen, which is based in Jamesburg, NJ, and Tel Aviv, also announced the opening of a business development, sales and marketing office in Sunnyvale, California. GenomeWeb first reported the planned opening of the facility last month.

The new site will be used as a launch pad for sales of Compugen's genomic and proteomic products on the West Coast.

“Being closer to our customers will enhance our ability to provide our solutions to our customers," Eli Mintz, president of Compugen, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.